American depository receipts of European stocks were 0.7% higher at 137.55 on the Bank of New York Mellon Europe ADR Index on Monday morning.
Gainers in Continental Europe were led by Oasmia Pharmaceutical ( OASM ), a Sweden-based pharmaceutical company, 14.6% higher, followed by Banco Santander ( SAN ), 3% higher and Logitech ( LOGI ), a Swiss hardware and software products developer, up by 2.9%. Materialise ( MTLS ), a Belgian provider of 3D printing software and services, was 2.7% higher.
In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, was 12.5% higher, Carnival (CUK), a cruise vacation company, was up by 2.9%, Astrazeneca (AZN), a biopharmaceutical company, was 1.7% higher and Amarin (AMRN), a biopharmaceutical company, was up by 1.6%.
Decliners in Continental Europe were led by Sanofi (SNY), a French healthcare company, down by 1.6%, Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, 1.4% lower, Edap (EDAP), a French medical devices developer, down by 1.3% and Cellectis (CLLS), a French genome engineering company, 1.3% lower.
And, in the UK, Randgold Resources (GOLD), a gold-mining company, was 1.4% lower, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was down by 1.0% and Royal Bank of Scotland (RBS) was down by 0.3%. Lloyds Banking Group (LYG) was down by 0.3%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
